SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950123-15-003124
Filing Date
2015-02-17
Accepted
2015-02-17 18:07:52
Documents
1
Group Members
VENROCK ASSOCIATES II, L.P.VENROCK ASSOCIATES V, L.P.VENROCK ENTREPRENEURS FUND, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS, L.P.VENROCK MANAGEMENT V, LLCVENROCK MANAGEMENT, LLCVENROCK PARTNERS MANAGEMENT V, LLCVENROCK PARTNERS V, L.P.VHCP CO-INVESTMENT HOLD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d873034dsc13ga.htm SC 13G/A 231856
  Complete submission text file 0000950123-15-003124.txt   233789
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

IRS No.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Subject) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-85292 | Film No.: 15624866
SIC: 2834 Pharmaceutical Preparations